Your SlideShare is downloading. ×
Antifungals market to 2017   generic erosion
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Antifungals market to 2017 generic erosion

202

Published on

Aarkstore.com 10% Discount || Antifungals Market to 2017 - Generic Erosion of Major ||

Aarkstore.com 10% Discount || Antifungals Market to 2017 - Generic Erosion of Major ||

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
202
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:Antifungals Market to 2017 - Generic Erosion of MajorPolyenes, Azoles, Allylamines and Echinocandins to SlowValue Growthhttp://www.aarkstore.com/reports/Antifungals-Market-to-2017-Generic-Erosion-of-Major-Polyenes-Azoles-Allylamines-and-Echinocandins-to-Slow-Value-Growth-107118.htmlIn-depth analysis of the report is based on propriety databases, primary andsecondary research and in-house analysis by the GBI Research team of experts.GBI Research analysis shows that the global antifungals market was estimated at$9.4 billion in 2010, with a Compound Annual Growth Rate (CAGR) of 2.9% during2002 and 2010. The antifungals market is dominated by generics. GBI Researchforecasts that the market will grow at a CAGR of 1.9% during 2010-2017 to $10.8billion. The patent expiry of a number of major drugs has paved way for the entry ofgenerics.GBI Research analysis shows that the R&D pipeline for the antifungals market is notstrong as it has become a generic market. Currently, only 38 molecules are in R&D,which indicates that antifungals R&D activity will not be very active for at least thenext seven to eight years.Scope•Data and analysis on the antifungals market in the leading geographies of the world- the US, the UK, Germany, France, Italy, Spain, and Japan.•Annualized market data for the antifungals market from 2002-2010 with forecaststo 2017.
  • 2. •Market data on the geographical landscape and therapeutic landscape, includingmarket size, market share, annual cost of therapy, sales volume and treatment usagepatterns such as disease population, treatment seeking population, diagnosispopulation and prescription population.Table of contents:1.1 List of Tables1.2 List of Figures2. Global Antifungals Market to 2017 - Introduction2.1 Overview2.2 GBI Research Report Guidance3. Global Antifungals Market to 2017 - Market Characterization3.1 Introduction3.2 Different Classes of Antifungals3.3 Forecast for Global Antifungals Market3.3.1 Revenues3.3.2 Branded and Generic Market Share3.3.3 Annual Cost of Treatment (ACT)3.3.4 Treatment Usage Patterns3.4 Drivers for the Antifungals Market3.4.1 Large Patient Population3.4.2 Increase in Diagnosis Rate3.5 Barriers for the Antifungals Market3.5.1 Prominence of Generics in the Market3.5.2 High Unmet Need in Case of Serious Invasive Fungal Infections4. Global Antifungals Market - Geographical Landscape4.1 Revenue Analysis by Geography4.2 The US4.2.1 Revenue4.2.2 Annual Cost of Treatment4.2.3 Treatment Usage Pattern4.3 Top Five Countries of Europe4.3.1 Revenue4.3.2 Annual Cost of Treatment4.3.3 Treatment Usage Pattern4.4 Japan
  • 3. 4.4.1 Revenue4.4.2 Annual Cost of TreatmentList of FiguresList of Tables are also include.For more DISCOUNT related Reports Plz follow The link:Cardiac Rhythm Management Devices Market to 2017 - Technological Innovations,Regulatory Approvals and Increasing Disease Prevalence Present GrowthOpportunitiesCardiac Assist Device Market to 2017 – Increasing Uptake of Ventricular AssistDevices and Total Artificial Heart to Drive GrowthGeneric Growth Strategies - Manufacturers to Increase Focus on Super Generics andBiosimilars to Drive RevenuesRx-to-OTC Switching Strategies - New Switching Opportunities in WeightManagement and Smoking Cessation, but Encouraging the Uptake of Self-MedicationRemains a ChallengeAntifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles, Allylaminesand Echinocandins to Slow Value GrowthSearch More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1
  • 4. Biobetters in Key Markets - Opportunities for Biotechnology Companies to SustainInnovation with Low Risk and High Value OfferingsGeneric Growth Strategies - Manufacturers to Increase Focus on Super Generics andBiosimilars to Drive RevenuesRx-to-OTC Switching Strategies - New Switching Opportunities in WeightManagement and Smoking Cessation, but Encouraging the Uptake of Self-MedicationRemains a ChallengeAntifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles,Allylamines and Echinocandins to Slow Value GrowthYou can also request for sample page of above mention reports onsample@aarkstore.comFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com

×